BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Leukemia
,
Pancreas
,
Laryngoscope
,
Fenofibrate
,
rs4950928
,
PRKCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ADAMTS7;jsessionid=17A11A95ED45BFC95092749BCC762DF1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Granulocyte-macrophage progenitor cell of bone marrow
Macrophage of peripheral blood
Parotid gland
Globus pallidus
Atrioventricular node
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
ADAMTS7: a Novel Therapeutic Target in Atherosclerosis.
BAY-9835: Discovery of the First Orally Bioavailable ADAMTS7 Inhibitor.
Investigating ADAMTS7 and ADAMTS12 levels in prediabetic and Type 2 diabetic patients.
Diagnostic value of serum COMP and ADAMTS7 for intervertebral disc degeneration.
The Association of ADAMTS7 Gene Polymorphisms with the Risk of Coronary Artery Disease Occurrence an…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for ADAMTS7;jsessionid=17A11A95ED45BFC95092749BCC762DF1
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ